Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 142.55 USD -5.9% Market Closed
Updated: Jun 1, 2024

Moderna Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Moderna Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Moderna Inc
NASDAQ:MRNA
Total Liabilities
$3.9B
CAGR 3-Years
-24%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$140.9B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$38.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$88B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.4B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
22%

See Also

What is Moderna Inc's Total Liabilities?
Total Liabilities
3.9B USD

Based on the financial report for Mar 31, 2024, Moderna Inc's Total Liabilities amounts to 3.9B USD.

What is Moderna Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
61%

Over the last year, the Total Liabilities growth was -26%. The average annual Total Liabilities growth rates for Moderna Inc have been -24% over the past three years , 61% over the past five years .